Bisphosphonates - Role in Cancer Therapies

被引：14

作者：

Mehrotra, Bhoomi ^{[1
,2
]}

机构：

[1] Long Isl Jewish Med Ctr, Div Med Oncol, New Hyde Pk, NY 11042 USA

[2] Albert Einstein Coll Med, New Hyde Pk, NY USA

来源：

JOURNAL OF ORAL AND MAXILLOFACIAL SURGERY | 2009年 / 67卷 / 05期

关键词：

PREVENTS BONE LOSS; ADVANCED MULTIPLE-MYELOMA; PLACEBO-CONTROLLED TRIAL; ZOLEDRONIC ACID; BREAST-CANCER; AMERICAN-SOCIETY; DOUBLE-BLIND; PAMIDRONATE DISODIUM; ADJUVANT CHEMOTHERAPY; POSTMENOPAUSAL WOMEN;

D O I：

10.1016/j.joms.2009.01.012

中图分类号：

R78 [口腔科学];

学科分类号：

1003 ;

摘要：

[No abstract available]

引用

页码：19 / 26

页数：8

共 43 条

[1] American Society of Clinical Oncology clinical practice guidelines: The role of bisphosphonates in multiple myeloma [J].

Berenson, JR ;

Hillner, BE ;

Kyle, RA ;

Anderson, K ;

Lipton, A ;

Yee, GC ;

Biermann, JS .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) :3719-3736

[2] Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].

Berenson, JR ;

Lichtenstein, A ;

Porter, L ;

Dimopoulos, MA ;

Bordoni, R ;

George, S ;

Lipton, A ;

Keller, A ;

Ballester, O ;

Kovacs, MJ ;

Blacklock, HA ;

Bell, R ;

Simeone, J ;

Reitsma, DJ ;

Heffernan, M ;

Seaman, J ;

Knight, RD .

NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493

[3] Long-term pamidronate treatment of advanced multiple myeloma patients reduces skeletal events [J].

Berenson, JR ;

Lichtenstein, A ;

Porter, L ;

Dimopoulos, MA ;

Bordoni, R ;

George, S ;

Lipton, A ;

Keller, A ;

Ballester, O ;

Kovacs, M ;

Blacklock, H ;

Bell, R ;

Simeone, JF ;

Reitsma, DJ ;

Heffernan, M ;

Seaman, J ;

Knight, RD .

JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (02) :593-602

[4] Integrated analysis of zoledronic acid for prevention of aromatase inhibitor-associated bone loss in postmenopausal women with early breast cancer receiving adjuvant letrozole [J].

Brufsky, Adam ;

Bundred, Nigel ;

Coleman, Robert ;

Lambert-Falls, Rosemary ;

Mena, Raul ;

Hadji, Peyman ;

Jin, Lixian ;

Schenk, Nora ;

Ericson, Solveig ;

Perez, Edith A. .

ONCOLOGIST, 2008, 13 (05) :503-514

[5] Zoledronic acid inhibits adjuvant letrozole-induced bone loss in postmenopausal women with early breast cancer [J].

Brufsky, Adam ;

Harker, W. Graydon ;

Beck, J. Thaddeus ;

Carroll, Robert ;

Tan-Chiu, Elizabeth ;

Seidler, Christopher ;

Hohneker, John ;

Lacerna, Leo ;

Petrone, Stephanie ;

Perez, Edith A. .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (07) :829-836

[6] Effective inhibition of aromatase inhibitor-associated bone loss by zoledronic acid in postmenopausal women with early breast cancer receiving adjuvant letrozole [J].

Bundred, Nigel J. ;

Campbell, Ian D. ;

Davidson, Neville ;

DeBoer, Richard H. ;

Eidtmann, Holger ;

Monnier, Alain ;

Neven, Patrick ;

von Minckwitz, Gunter ;

Miller, Joel C. ;

Schenk, Nora L. ;

Coleman, Robert E. .

CANCER, 2008, 112 (05) :1001-1010

[7] Five years of letrozole compared with tamoxifen as initial adjuvant therapy for postmenopausal women with endocrine-responsive early breast cancer:: Update of study BIG 1-98 [J].

Coates, Alan S. ;

Keshaviah, Aparna ;

Thuerlimann, Beat ;

Mouridsen, Henning ;

Mauriac, Louis ;

Forbes, John F. ;

Paridaens, Robert ;

Castiglione-Gertsch, Monica ;

Gelber, Richard D. ;

Colleoni, Marco ;

Lang, Istvan ;

Del Mastro, Lucia ;

Smith, Ian ;

Chirgwin, Jacquie ;

Nogaret, Jean-Marie ;

Pienkowski, Tadeusz ;

Wardley, Andrew ;

Jakobsen, Erik H. ;

Price, Karen N. ;

Goldhirsch, Aron .

JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (05) :486-492

[8] Delay in progression of bone metastases in breast cancer patients treated with intravenous pamidronate: Results from a multinational randomized controlled trial [J].

Conte, PF ;

Latreille, J ;

Mauriac, L ;

Calabresi, F ;

Santos, R ;

Campos, D ;

Bonneterre, J ;

Francini, G ;

Ford, JM .

JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (09) :2552-2559

[9] Survival and safety of exemestane versus tamoxifen after 2-3 years' tamoxifen treatment (Intergroup Exemestane Study): a randomised controlled trial [J].

Coombes, R. C. ;

Kilburn, L. S. ;

Snowdon, C. F. ;

Paridaens, R. ;

Coleman, R. E. ;

Jones, S. E. ;

Jassem, J. ;

Van de Velde, C. J. H. ;

Delozier, T. ;

Alvarez, I. ;

Del Mastro, L. ;

Ortmann, O. ;

Diedrich, K. ;

Coates, A. S. ;

Bajetta, E. ;

Holmberg, S. B. ;

Dodwell, D. ;

Mickiewicz, E. ;

Andersen, J. ;

Lonning, P. E. ;

Cocconi, G. ;

Forbes, J. ;

Castiglione, M. ;

Stuart, N. ;

Stewart, A. ;

Fallowfield, L. J. ;

Bertelli, G. ;

Hall, E. ;

Bogle, R. G. ;

Carpentieri, M. ;

Colajori, E. ;

Subar, M. ;

Ireland, E. ;

Bliss, J. M. .

LANCET, 2007, 369 (9561) :559-570

[10] Bisphosphonate risedronate prevents bone loss in women with artificial menopause due to chemotherapy of breast cancer: A double-blind, placebo-controlled study [J].

Delmas, PD ;

Balena, R ;

Confravreux, E ;

Hardouin, C ;

Hardy, P ;

Bremond, A .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (03) :955-962

← 1 2 3 4 5 →